Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2022-06-15 00:00:00 ET · period of report 2022-06-13 · accession 0001437749-22-015019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-06-15 | 2022-06-13+ | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $1.69 | +3,500 | 63.0K | +6% | +$5,908 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | A | A | 3,000 | $1.69 | 62,584 | D | — | — | (F1) Holdings do not include options to purchase 20,834 shares. |
| 2 | Common | Common Stock | 2022-06-13 | A | A | 84 | $1.70 | 59,584 | D | — | — | (F1) Holdings do not include options to purchase 20,834 shares. |
| 3 | Common | Common Stock | 2022-06-14 | A | A | 416 | $1.67 | 63,000 | D | — | — | (F1) Holdings do not include options to purchase 20,834 shares. |